BCL2 and breast cancer: However, studies from Zoli, et al. [18] suggest that 5-Fu in combination with doxorubicin and paclitaxel regulates CASP8 and induces cell apoptosis by a caspase-dependent mechanism independent of hormonal, p53, bcl-2 or bax status in breast cancer cells [18].